Skip to main content
. Author manuscript; available in PMC: 2023 Mar 15.
Published in final edited form as: Biomater Sci. 2023 Mar 14;11(6):2065–2079. doi: 10.1039/d2bm00819j

Fig. 4.

Fig. 4

Centi-C10 antibody properties and discovery process. a) Centi-C10 potency quantified by neutralization assays of spike-pseudotyped lentivirus (mean ± SD, assayed in duplicate). b) Antibodies capable of binding the SARS-CoV-2 receptor binding domain (RBD), and thus blocking the binding of the virus to ACE-2 receptors on human cells, were discovered by multiple rounds of panning and selection from an ScFV phage library built from a SARS-CoV-1-binding parental antibody.